MX2017007476A - Recipiente precargado con toxina botulinica. - Google Patents
Recipiente precargado con toxina botulinica.Info
- Publication number
- MX2017007476A MX2017007476A MX2017007476A MX2017007476A MX2017007476A MX 2017007476 A MX2017007476 A MX 2017007476A MX 2017007476 A MX2017007476 A MX 2017007476A MX 2017007476 A MX2017007476 A MX 2017007476A MX 2017007476 A MX2017007476 A MX 2017007476A
- Authority
- MX
- Mexico
- Prior art keywords
- botulinum toxin
- container
- prefilled
- prefilled container
- toxin prefilled
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/3129—Syringe barrels
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C1/00—Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
- A61K38/4893—Botulinum neurotoxin (3.4.24.69)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31511—Piston or piston-rod constructions, e.g. connection of piston with piston-rod
- A61M5/31513—Piston constructions to improve sealing or sliding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/24—Metalloendopeptidases (3.4.24)
- C12Y304/24069—Bontoxilysin (3.4.24.69), i.e. botulinum neurotoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/87—Application Devices; Containers; Packaging
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/91—Injection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/3129—Syringe barrels
- A61M2005/3131—Syringe barrels specially adapted for improving sealing or sliding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/02—General characteristics of the apparatus characterised by a particular materials
- A61M2205/0222—Materials for reducing friction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/02—General characteristics of the apparatus characterised by a particular materials
- A61M2205/0238—General characteristics of the apparatus characterised by a particular materials the material being a coating or protective layer
Abstract
La presente invención se relaciona con un recipiente de vidrio precargado, tal como una jeringa de vidrio precargada, que comprende una formulación de toxina botulínica acuosa. La formulación de toxina botulínica acuosa en el recipiente precargado es estable de temperatura baja a temperatura ambiente durante un período de tiempo prolongado. Además, la presente invención se relaciona con un kit que comprende el recipiente precargado con toxina botulínica, y con el uso de un recipiente precargado con toxina botulínica en aplicaciones terapéuticas y cosméticas.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP14004394 | 2014-12-23 | ||
PCT/EP2015/002602 WO2016102068A1 (en) | 2014-12-23 | 2015-12-22 | Botulinum toxin prefilled container |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2017007476A true MX2017007476A (es) | 2018-01-25 |
Family
ID=52302037
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2017007476A MX2017007476A (es) | 2014-12-23 | 2015-12-22 | Recipiente precargado con toxina botulinica. |
Country Status (15)
Country | Link |
---|---|
US (3) | US10549042B2 (es) |
EP (2) | EP3590500A1 (es) |
JP (1) | JP6798993B2 (es) |
KR (1) | KR102557798B1 (es) |
CN (1) | CN107106780B (es) |
AR (1) | AR103243A1 (es) |
AU (1) | AU2015371726B2 (es) |
CA (1) | CA2971238C (es) |
ES (1) | ES2788999T3 (es) |
IL (1) | IL252749B (es) |
MX (1) | MX2017007476A (es) |
RU (1) | RU2694820C9 (es) |
SG (1) | SG11201705019PA (es) |
TW (1) | TWI669129B (es) |
WO (1) | WO2016102068A1 (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9180081B2 (en) * | 2005-03-03 | 2015-11-10 | Revance Therapeutics, Inc. | Compositions and methods for topical application and transdermal delivery of botulinum toxins |
US8168206B1 (en) | 2005-10-06 | 2012-05-01 | Allergan, Inc. | Animal protein-free pharmaceutical compositions |
BRPI0923731B1 (pt) | 2008-12-31 | 2024-02-06 | Revance Therapeutics, Inc | Composições para uso em um método não-terapêutico de administração de toxina botulínica, seus usos e método de preparação |
CN102869373B (zh) | 2009-06-25 | 2017-05-10 | 雷文斯治疗公司 | 不含白蛋白的肉毒杆菌毒素制剂 |
AU2015371726B2 (en) | 2014-12-23 | 2020-10-22 | Merz Pharma Gmbh & Co. Kgaa | Botulinum toxin prefilled container |
SG11201706247VA (en) * | 2015-02-03 | 2017-08-30 | Merz Pharma Gmbh & Co Kgaa | Botulinum toxin prefilled container |
WO2018011190A1 (en) * | 2016-07-11 | 2018-01-18 | Becton Dickinson France | Method for reducing an amount of subvisible particles in a pharmaceutical composition |
MX2019009860A (es) * | 2017-03-24 | 2019-10-15 | Merz Pharma Gmbh & Co Kgaa | Uso mejorado de neurotoxina botulinica en el tratamiento de sialorrea. |
KR102091452B1 (ko) * | 2017-12-19 | 2020-03-20 | 대화제약 주식회사 | 국소 마취제 및 히알루론산 하이드로겔을 포함하는 사전충전형 주사기의 제조방법 |
WO2020169578A1 (en) | 2019-02-21 | 2020-08-27 | Merz Pharma Gmbh & Co. Kgaa | Novel uses of botulinum neurotoxin for the treatment of tremor |
EP3851421A1 (en) * | 2020-01-16 | 2021-07-21 | Schott Ag | Glass container for pharamceutical, medical or cosmetic applications |
US20230165946A1 (en) * | 2020-04-08 | 2023-06-01 | Medytox Inc. | Botulinum toxin pre-filled injectable formulation that facilitates discharge rate control and is stable |
Family Cites Families (66)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2604597Y2 (ja) * | 1993-03-02 | 2000-05-22 | 生化学工業株式会社 | 薬剤入り注射具 |
JP3634560B2 (ja) * | 1997-05-20 | 2005-03-30 | テルモ株式会社 | 既充填薬液容器 |
TW574036B (en) * | 1998-09-11 | 2004-02-01 | Elan Pharm Inc | Stable liquid compositions of botulinum toxin |
US20060269575A1 (en) * | 2000-02-08 | 2006-11-30 | Allergan, Inc. | Botulinum toxin pharmaceutical compositions formulated with recombinant albumin |
EP1586329A1 (en) | 2000-02-08 | 2005-10-19 | Allergan, Inc. | Botulinum toxin pharmaceutical compositions |
EP1276849A4 (en) * | 2000-04-12 | 2004-06-09 | Human Genome Sciences Inc | ALBUMIN FUSION PROTEINS |
US7374896B2 (en) | 2001-08-28 | 2008-05-20 | Allergan, Inc. | GFP-SNAP25 fluorescence release assay for botulinum neurotoxin protease activity |
US7183066B2 (en) | 2002-09-27 | 2007-02-27 | Allergan, Inc. | Cell-based fluorescence resonance energy transfer (FRET) assays for clostridial toxins |
DE10333317A1 (de) * | 2003-07-22 | 2005-02-17 | Biotecon Therapeutics Gmbh | Formulierung für Proteinarzneimittel ohne Zusatz von humanem Serumalbumin (HSA) |
US20050075611A1 (en) | 2003-10-01 | 2005-04-07 | Hetzler Kevin G. | Low extractable, thermoplastic syringe and tip cap |
US8379864B2 (en) | 2004-07-09 | 2013-02-19 | Nokia Corporation | Software plug-in framework to modify decryption methods in terminals |
GB2416122A (en) * | 2004-07-12 | 2006-01-18 | Ipsen Ltd | Botulinum neurotoxin composition |
US20080045889A1 (en) * | 2004-07-21 | 2008-02-21 | Gerondale Scott J | Botoxo Needle Injector |
DE102004043009A1 (de) | 2004-09-06 | 2006-03-23 | Toxogen Gmbh | Transportprotein zum Einbringen chemischer Verbindungen in Nervenzellen |
DE102005019302A1 (de) | 2005-04-26 | 2006-11-16 | Toxogen Gmbh | Carrier zum Targeting von Nervenzellen |
US8137677B2 (en) | 2005-10-06 | 2012-03-20 | Allergan, Inc. | Non-protein stabilized clostridial toxin pharmaceutical compositions |
EP1834962A1 (de) | 2006-03-15 | 2007-09-19 | Biotecon Therapeutics GmbH | PEGyliertes mutiertes Clostridium botulinum Toxin |
WO2008127290A2 (en) * | 2006-10-12 | 2008-10-23 | The Johns Hopkins University | Alginate and alginate lyase compositions and methods of use |
US8455072B2 (en) | 2006-12-22 | 2013-06-04 | Basell Poliolefine Italia S.R.L. | Polyolefin composition for pipe system and sheets |
GB0700523D0 (en) * | 2007-01-11 | 2007-02-21 | Insense Ltd | The Stabilisation Of Proteins |
ES2520765T3 (es) * | 2007-02-15 | 2014-11-11 | Allergan, Inc. | Uso de toxina botulínica para el tratamiento de hiperhidrosis |
JP2010529000A (ja) | 2007-06-01 | 2010-08-26 | メルツ・ファルマ・ゲーエムベーハー・ウント・コ・カーゲーアーアー | ボツリヌス毒素の神経毒成分をベースにした温度に安定な筋弛緩薬の提供方法 |
EP2048156A1 (en) * | 2007-10-12 | 2009-04-15 | Merz Pharma GmbH & Co.KGaA | Process for providing a temperature-stable muscle relaxant on the basis of the neurotoxic component of botulinum toxin |
EP1997509A1 (en) * | 2007-06-01 | 2008-12-03 | Merz Pharma GmbH & Co.KGaA | Process for providing a temperature-stable muscle relaxant on the basis of the neurotoxic component of botulinum toxin |
WO2009003010A2 (en) | 2007-06-25 | 2008-12-31 | Becton, Dickinson And Company | Methods for evaluating the aggregation of a protein in a suspension including organopolysiloxane and medical articles coated with organopolysiloxane containing a protein solution |
JP5259710B2 (ja) | 2007-07-10 | 2013-08-07 | メディ‐トックス、インク. | ボツリヌス毒素の安定性が改善された薬学的液状組成物 |
WO2009015840A2 (en) | 2007-07-27 | 2009-02-05 | Merz Pharma Gmbh & Co. Kgaa | Polypeptide for targeting of neural cells |
BR122012027456A2 (pt) | 2008-03-14 | 2015-07-14 | Allergan Inc | Composição farmacêutica compreendendo sorotipo de neurotoxina botulínica a |
BRPI0916964A2 (pt) | 2008-08-29 | 2015-11-24 | Merz Pharma Gmbh & Co Kgaa | polipetídeo, anticorpo, ácido nucléico, vetor, célula hospedeira, método para produzir um polipeptídeo, composição e uso do polipeptídeo |
EP2364168A1 (en) | 2008-12-04 | 2011-09-14 | Botulinum Toxin Research Associates, Inc. | Extended length botulinum toxin formulation for human or mammalian use |
US20100216667A1 (en) | 2008-12-17 | 2010-08-26 | Meyer Brian K | Method for determining compatibility of an active pharmaceutical ingredient with materials |
US8535062B2 (en) * | 2008-12-23 | 2013-09-17 | Simskin, Llc | Cutaneous surgical training model of the head, neck and shoulders |
BRPI0923731B1 (pt) * | 2008-12-31 | 2024-02-06 | Revance Therapeutics, Inc | Composições para uso em um método não-terapêutico de administração de toxina botulínica, seus usos e método de preparação |
EP2248518B1 (en) * | 2009-04-17 | 2013-01-16 | Merz Pharma GmbH & Co. KGaA | Formulation for stabilizing proteins, peptides or mixtures thereof. |
CN102869373B (zh) | 2009-06-25 | 2017-05-10 | 雷文斯治疗公司 | 不含白蛋白的肉毒杆菌毒素制剂 |
IN2012DN00733A (es) | 2009-07-02 | 2015-06-19 | Merz Pharma Gmbh & Co Kgaa | |
EP2839855A3 (en) | 2009-10-19 | 2015-08-19 | Terumo Medical Corporation | Syringe assemblies having detachable needle assemblies and low dead space |
US10471212B2 (en) * | 2009-10-29 | 2019-11-12 | W. L. Gore & Associates, Inc. | Silicone free drug delivery devices |
US20130211344A1 (en) | 2009-12-31 | 2013-08-15 | Nestor Rodriguez | Medical components having coated surfaces exhibiting low friction and/or low gas/liquid permeability |
US20130078295A1 (en) * | 2010-06-09 | 2013-03-28 | Lipotec S.A. | Skin antiaging treatment |
CA2811640A1 (en) | 2010-10-06 | 2012-04-12 | Allergan, Inc. | System for storage and subsequent handling of botulinum toxin |
KR101640694B1 (ko) | 2011-09-29 | 2016-07-18 | 셀스냅, 엘엘씨 | 독소생산능 시험용 조성물 및 방법 |
MX363226B (es) | 2011-10-31 | 2019-03-15 | Genentech Inc | Formulaciones de anticuerpos. |
RU2646110C2 (ru) | 2011-11-09 | 2018-03-01 | Мерц Фарма Гмбх Унд Ко. Кгаа | Нейротоксины, проявляющие укороченную биологическую активность |
US9554968B2 (en) * | 2013-03-11 | 2017-01-31 | Sio2 Medical Products, Inc. | Trilayer coated pharmaceutical packaging |
EP2776603B1 (en) * | 2011-11-11 | 2019-03-06 | SiO2 Medical Products, Inc. | PASSIVATION, pH PROTECTIVE OR LUBRICITY COATING FOR PHARMACEUTICAL PACKAGE, COATING PROCESS AND APPARATUS |
US20150297800A1 (en) * | 2012-07-03 | 2015-10-22 | Sio2 Medical Products, Inc. | SiOx BARRIER FOR PHARMACEUTICAL PACKAGE AND COATING PROCESS |
US9133412B2 (en) | 2012-07-09 | 2015-09-15 | Tribofilm Research, Inc. | Activated gaseous species for improved lubrication |
WO2014026161A1 (en) * | 2012-08-10 | 2014-02-13 | Aquavit Pharmaceuticals, Inc. | Vitamin supplement compositions for injection |
US10980865B2 (en) * | 2012-08-10 | 2021-04-20 | Aquavit Pharmaceuticals, Inc. | Direct application system and method for the delivery of bioactive compositions and formulations |
WO2015020982A2 (en) * | 2013-08-04 | 2015-02-12 | Aquavit Pharmaceuticals, Inc. | Direct application system and method for the delivery of bioactive compositions and formulations |
WO2014052792A1 (en) | 2012-09-28 | 2014-04-03 | Sio2 Medical Products, Inc. | Halogenated or parylene polymer coating |
US20160015898A1 (en) * | 2013-03-01 | 2016-01-21 | Sio2 Medical Products, Inc. | Plasma or cvd pre-treatment for lubricated pharmaceutical package, coating process and apparatus |
US9937099B2 (en) * | 2013-03-11 | 2018-04-10 | Sio2 Medical Products, Inc. | Trilayer coated pharmaceutical packaging with low oxygen transmission rate |
US9863042B2 (en) * | 2013-03-15 | 2018-01-09 | Sio2 Medical Products, Inc. | PECVD lubricity vessel coating, coating process and apparatus providing different power levels in two phases |
WO2014207109A1 (en) | 2013-06-28 | 2014-12-31 | Merz Pharma Gmbh & Co. Kgaa | Means and methods for the determination of the biological activity of neurotoxin polypeptides in cells |
RU2663136C2 (ru) * | 2013-07-30 | 2018-08-01 | Мерц Фарма Гмбх Унд Ко. Кгаа | Способ получения высокочистого нейротоксического компонента ботулотоксина и его применения |
DE102014101305A1 (de) * | 2014-02-03 | 2015-08-06 | Heraeus Medical Gmbh | Vorrichtung zum Lagern und Mischen von Knochenzement |
RU2708974C2 (ru) | 2014-10-30 | 2019-12-12 | Ф. Хоффманн-Ля Рош Аг | Шприц и способ подготовки шприца |
AU2015371726B2 (en) * | 2014-12-23 | 2020-10-22 | Merz Pharma Gmbh & Co. Kgaa | Botulinum toxin prefilled container |
SG11201706247VA (en) * | 2015-02-03 | 2017-08-30 | Merz Pharma Gmbh & Co Kgaa | Botulinum toxin prefilled container |
US20180128133A1 (en) * | 2015-05-15 | 2018-05-10 | Eaton Corporation | Latch orientation mechanism |
EP3294305A4 (en) * | 2015-05-15 | 2019-02-13 | Carilion Clinic | SYRINGES AND METHOD FOR USE THEREOF FOR THE TREATMENT OF BLADDER HYPERACTIVITY |
US9827282B2 (en) * | 2015-07-24 | 2017-11-28 | Bao Tran | Medication dispensing system |
US10110405B2 (en) | 2015-11-05 | 2018-10-23 | Qualcomm Incorporated | System and method for narrowband uplink single tone transmissions |
TWI737742B (zh) * | 2016-06-22 | 2021-09-01 | 德商梅茲製藥有限兩合公司 | 肉毒桿菌毒素的預填充式注射器系統、具有其之套組以及其之使用 |
-
2015
- 2015-12-22 AU AU2015371726A patent/AU2015371726B2/en active Active
- 2015-12-22 TW TW104143035A patent/TWI669129B/zh active
- 2015-12-22 WO PCT/EP2015/002602 patent/WO2016102068A1/en active Application Filing
- 2015-12-22 AR ARP150104253A patent/AR103243A1/es unknown
- 2015-12-22 EP EP19193112.0A patent/EP3590500A1/en active Pending
- 2015-12-22 ES ES15823134T patent/ES2788999T3/es active Active
- 2015-12-22 CN CN201580069352.5A patent/CN107106780B/zh active Active
- 2015-12-22 KR KR1020177020499A patent/KR102557798B1/ko active IP Right Grant
- 2015-12-22 SG SG11201705019PA patent/SG11201705019PA/en unknown
- 2015-12-22 RU RU2017120836A patent/RU2694820C9/ru active
- 2015-12-22 CA CA2971238A patent/CA2971238C/en active Active
- 2015-12-22 US US15/536,503 patent/US10549042B2/en active Active
- 2015-12-22 EP EP15823134.0A patent/EP3236939B1/en active Active
- 2015-12-22 MX MX2017007476A patent/MX2017007476A/es unknown
- 2015-12-22 JP JP2017533920A patent/JP6798993B2/ja active Active
-
2017
- 2017-06-07 IL IL252749A patent/IL252749B/en active IP Right Grant
-
2019
- 2019-12-18 US US16/718,236 patent/US11167090B2/en active Active
-
2021
- 2021-06-23 US US17/356,300 patent/US20210316077A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
CA2971238A1 (en) | 2016-06-30 |
EP3236939A1 (en) | 2017-11-01 |
JP6798993B2 (ja) | 2020-12-09 |
ES2788999T3 (es) | 2020-10-23 |
WO2016102068A1 (en) | 2016-06-30 |
SG11201705019PA (en) | 2017-07-28 |
AU2015371726A1 (en) | 2017-07-06 |
CA2971238C (en) | 2022-12-13 |
AR103243A1 (es) | 2017-04-26 |
US20200121855A1 (en) | 2020-04-23 |
EP3590500A1 (en) | 2020-01-08 |
CN107106780B (zh) | 2020-10-16 |
KR102557798B1 (ko) | 2023-07-19 |
US10549042B2 (en) | 2020-02-04 |
RU2017120836A (ru) | 2019-01-24 |
RU2017120836A3 (es) | 2019-01-31 |
US20210316077A1 (en) | 2021-10-14 |
KR20170103837A (ko) | 2017-09-13 |
IL252749A0 (en) | 2017-08-31 |
EP3236939B1 (en) | 2020-04-01 |
JP2018500109A (ja) | 2018-01-11 |
IL252749B (en) | 2020-09-30 |
US20170340823A1 (en) | 2017-11-30 |
TW201636046A (zh) | 2016-10-16 |
RU2694820C2 (ru) | 2019-07-17 |
TWI669129B (zh) | 2019-08-21 |
CN107106780A (zh) | 2017-08-29 |
AU2015371726B2 (en) | 2020-10-22 |
US11167090B2 (en) | 2021-11-09 |
RU2694820C9 (ru) | 2019-08-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2017007476A (es) | Recipiente precargado con toxina botulinica. | |
MX2017009380A (es) | Recipiente precargado con toxina botulinica. | |
MX2018007703A (es) | Inhibidores de la interaccion de menina-linaje leucemico mixto. | |
PH12015500115B1 (en) | Glucagon analogues | |
AU367093S (en) | Medical injector | |
AU353353S (en) | Medical syringe | |
MX2018006171A (es) | Jeringa de plastico precargada que contiene un antagonista de vegf. | |
TR201906843T4 (tr) | Hızlı etkili insülin bileşimleri. | |
MX2016005395A (es) | Formulacion estable de insulina glulisina. | |
MX2018000570A (es) | Nuevas isoformas de tripsina y su uso. | |
AU357673S (en) | Mirror housing | |
MX2017012596A (es) | Una composicion farmaceutica y el uso de la misma. | |
HK1232165A1 (zh) | 注射器蓋、帶針注射器、及預充式注射器製劑 | |
TN2015000406A1 (en) | Antimicrobial compositions and related methods of use | |
MX2016015261A (es) | Dispersion solida de allisartan isoproxilo y su composicion. | |
MX2016005545A (es) | Analogo de la relaxina humana, composicion farmaceutica del mismo y aplicacion farmaceutica del mismo. | |
MX370990B (es) | Ésteres de ácidos oligo-hidroxicarboxílicos y uso de los mismos. | |
MX2015016490A (es) | Esteres sulfatados de acidos oligohidroxicarboxilicos, y uso de los mismos. | |
PH12017500661A1 (en) | Reduced foaming vaccine compositions | |
MX2017009313A (es) | Formulaciones intravenosas de baclofeno y metodos de tratamiento. | |
EA201890209A1 (ru) | Композиция, содержащая танины | |
EA201700074A1 (ru) | Стабильные не содержащие консерванты офтальмологические составы опиоидных антагонистов | |
EP3025746A4 (en) | Gasket, and plunger, syringe, and prefilled syringe which use same | |
BR112017013764A2 (pt) | recipiente pré-carregado com toxina botulínica | |
GEP20207145B (en) | Combination of trazodone and gabapentin for the treatmen |